Related Articles
Prognostic value of serum leptin in advanced lung adenocarcinoma patients with cisplatin/pemetrexed chemotherapy
Clinical value of serum tumor markers CA19‑9, CA125 and CA72-4 in the diagnosis of pancreatic carcinoma
SUVmax of 18F-FDG PET/CT correlates to expression of major chemotherapy-related tumor markers and serum tumor markers in gastric adenocarcinoma patients
Association between carcinoembryonic antigen, carbohydrate antigen 19‑9 and body mass index in colorectal cancer patients
An explorative study on the clinical utility of baseline and serial serum tumour marker measurements in advanced upper gastrointestinal cancer